Clinical Performance of Flowable Giomer Versus Nanofilled Composite in Conservative Occlusal Cavities
Launched by CAIRO UNIVERSITY · Oct 20, 2023
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different materials used for filling cavities in teeth, specifically focusing on a new product called Flowable Giomer and a commonly used material called Nanofilled Composite. The main goal is to see how well these two materials perform when used to treat small cavities in the chewing surfaces of permanent molars. The researchers want to find out if the new Flowable Giomer works just as well as the traditional composite material, which is important for ensuring patients receive the best possible care.
To participate in this study, candidates must be generally healthy and have small cavities in their teeth. However, certain conditions could exclude someone from joining, such as having severe medical issues, being pregnant, or having specific dental problems. If eligible, participants will receive a filling with either the new material or the standard one, and they will be monitored to see how well the filling holds up over time. This trial is an important step in evaluating new dental materials and improving cavity treatment options for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Unilateral or Bilateral small Class I carious lesions
- • Patients with good oral health
- • Small Class I carious lesion in occlusal pits and fissures
- Exclusion Criteria:
- • Existing systemic diseases
- • Severe medical complications
- • Allergy history concerning methacrylates
- • Pregnancy
- • Heavy smoking
- • Evidence of severe bruxism, clenching or temporomandibular joint disorders
- • Presence of existing occlusal restoration
- • Periapical or pulpal pathology
- • Tooth hypersensitivity
- • Possible prosthodontic restoration of teeth
- • Endodontically treated teeth
- • Severe periodontal affection
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported